- Guide to PHARMACOLOGY
Synonyms: compound 23 [PMID: 29526098] | eFT-508 | eFT508
Compound class: Synthetic organic
Comment: Tomivosertib (eFT508) is an orally active and selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2) inhibitor that is being developed by eFFECTOR Therapeutics for anti-neoplastic potential .
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Tomivosertib selectively regulates the production of pro-inflammatory cytokines and chemokines (e.g. TNFα, IL-6, and IL-8) in model systems . This potential reshaping of the tumour micorenvironment is likely to contribute to its anti-tumour efficacy, given the pro-tumourigenic role played by tumour-driven inflammation in various cancer types .|